Updates

October 1, 2026 To, To, Listing / Compliance Department Listing / Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers “Exchange Plaza”, Plot No C/1, Dalal Street, Mumbai 400 001. G Block, Bandra Kurla Complex, Bandra (E), Mumbai 400 051. Scrip Code: 543210 Symbol: AARTISURF Dear Sir / Madam, Sub: Change in Management Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and based on the report of the Scrutinizer dated September 30, 2026, we wish to inform you that the Members of the Company at the 8th Annual General Meeting (“AGM”) held on Tuesday, September 29, 2026, have, inter alia, approved the following: 1. Re-appointment of Mr. Nikhil P. Desai (DIN: 01660649) as CEO & Managing Director of the Company, for a period of 5 (five) years with effect from August 20, 2027. 2. Re-appointment of Mr. Santosh M. Kakade (DIN: 08505234) as the Whole-time Director designated as an Executive Director of the company, for a period of 5 (five) years with effect from August 20, 2027. The requisite details relating to the re-appointments of Mr. Nikhil P. Desai and Mr. Santosh M. Kakade, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with the SEBI Master Circular dated January 30, 2026, are annexed hereto as Annexure A. 3. Appointment of Prof. Vandana B. Patravale (DIN: 09200693), as an Independent Director of the Company for a period of 5 (five) years with effect from August 22, 2026. The requisite details relating to the appointment, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with the SEBI Master Circular dated January 30, 2026, is annexed hereto as Annexure B. We hereby confirm that Mr. Nikhil P. Desai, Mr. Santosh M. Kakade and Prof. Vandana B. Patravale are not debarred from holding the office of a Director pursuant to any order of SEBI or any other such authority. The above information is also available on the website of the Company at www.aarti-surfactants.com. Kindly take the above information on record. Thanking you, Yours faithfully, For Aarti Surfactants Limited Priyanka Chaurasia Company Secretary ICSI M. NO. A44258 Annexure A Disclosure of information pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Schedule III and SEBI Master Circular dated January 30, 2026: Sr. Particulars Mr. Nikhil P. Desai Mr. Santosh M. Kakade 1. Reason for Changes Re-appointment of Mr. Nikhil Re-appointment of Mr. Santosh viz. appointment, P. Desai (DIN: 01660649) as M. Kakade (DIN: 08505234) as reappointment, CEO & Managing Director of the Whole-time Director resignation, removal, the Company. designated as an Executive death or otherwise; Director of the Company. 2 Date of appointment / Re-appointment for a Re-appointment for a reappointment / consecutive term of 5 (five) consecutive term of 5 (five) cessation (as years, effective from August years, effective from August 20, applicable) & term of 20, 2027 to August 19, 2032. 2027 to August 19, 2032. appointment / re - appointment; Mr. Nikhil P. Desai shall not be Mr. Santosh M. Kakade shall be liable to retire by rotation. liable to retire by rotation. 3 Brief Profile (in case Mr. Nikhil P. Desai has over 20 Mr. Santosh M. Kakade has of appointment); years of rich experience across more than three decades of Information Technology, diverse experience in the fields Project Management, of Plant Operations, Process Technical Sales, Vendor Development, Project Management, Team Building, Management, and General Process Improvement, Management. Business Strategy, Change Management, Marketing and Product Development, with significant exposure to the pharmaceutical and chemical industries. 4 Disclosure of Mr. Nikhil P. Desai is the son of Mr. Santosh M. Kakade is not relationships between Mr. Parimal H. Desai, Non- related to any Director of the directors, (in case of Executive Director and Company. appointment of a Promoter of the Company. director) He also forms part of the Promoter Group of the Company. Annexure B Disclosure of information pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Schedule III and SEBI Master Circular dated January 30, 2026: Sr. No. Particulars Prof. Vandana B. Patravale 1 Reason for Changes viz. Appointment of Prof. Vandana B. Patravale (DIN: appointment, reappointment, 09200693), as an Independent Director of the resignation, removal, death or Company. otherwise; 2 Date of appointment / re - Appointment for a consecutive term of 5 (five) years, appointment / cessation (as commencing from August 22, 2026 and ending on applicable) & term of appointment August 21, 2031. / re - appointment; 3 Brief Profile (in case of Prof. Vandana B. Patravale holds B. Pharm., M. appointment); Pharm. and Ph.D. (By Research, in Pharmaceutics) degrees from the University of Mumbai and is a Senior Professor of Pharmaceutics at the Institute of Chemical Technology (ICT), Mumbai, with over 35 years of academic, research and industry-oriented experience. Her areas of expertise include Pharmaceutics, Cosmeticology, Validation and Regulatory Affairs, and Advanced Pharmaceutics. She has supervised numerous research projects and has made significant contributions to the development of novel nanocarriers for cosmeceuticals and applications in areas of national relevance, including malaria, cancer and neurodegenerative disorders. She has an extensive portfolio of research publications and intellectual property, including several Indian and International patents. She has received several prestigious awards, including the Abdul Kalam National Innovation Fellowship, OPPI Woman Scientist Award, VASVIK Industrial Research Award and UAA-ICT Distinguished Alumnus Award etc. She has also played a significant role in the successful transfer of several Pharmaceutical Technologies. 4 Disclosure of relationships between Prof. Vandana B. Patravale is not related to any directors, (in case of appointment of Director of the Company. a director)